MARKET

PTIX

PTIX

Protagenic
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.770
0.000
0.00%
Pre Market: 2.770 0 0.00% 07:02 06/23 EDT
OPEN
2.800
PREV CLOSE
2.770
HIGH
2.880
LOW
2.621
VOLUME
435
TURNOVER
--
52 WEEK HIGH
7.00
52 WEEK LOW
1.050
MARKET CAP
40.56M
P/E (TTM)
-8.8527
1D
5D
1M
3M
1Y
5Y
58 Biggest Movers From Friday
Gainers CAI International, Inc. (NYSE: CAI) shares surged 46.9% to close at $56.05 on Friday after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc.
Benzinga · 2d ago
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers
Benzinga · 5d ago
Protagenic Therapeutics to Present at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference on June 17th
Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a bioharmaceutical company focused on developing drug product candidates to treat stress-related neurologic disorders, today announced will be presenting at the H.C. Wainwright Psychedelics in Psychiatry and Bey...
GlobeNewswire · 6d ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Benzinga · 06/15 12:17
12 Health Care Stocks Moving In Monday's Intraday Session
 
Benzinga · 06/14 16:58
64 Biggest Movers From Friday
Gainers Kanzhun Limited (NASDAQ: BZ) shares climbed 95.8% to close at $37.20 on Friday after the company priced its IPO at $19 per share.
Benzinga · 06/14 09:04
Healthcare names dominate premarket gainers
Amesite (AMST) +61%.GBS (GBS) +40%.Novan (NOVN) +37% on positive results for SB206 in skin infection.Precigen (PGEN) +31% on positive topline results from phase 1b/2a study of AG019 ActoBiotics™.Protagenic Therapeutics (PTIX) +28%.Magnachip Semiconductor
Seekingalpha · 06/11 12:28
IVR, RH, ASAN and EDU among premarket gainers
Medley Management (MDLY) +79%.Orbsat Corp (OSAT) +38%.Sphere 3D Corp. (ANY) +30%.Xinyuan Real Estate (XIN) +26% after announcing the completion of five newly constructed properties.Zivo Bioscience (ZIVO) +21%.China HGS Real Estate (HGSH)
Seekingalpha · 06/10 12:17
More
Forecast
No Data
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of PTIX. Analyze the recent business situations of Protagenic through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+0.14%
Pharmaceuticals & Medical Research
-0.24%
Key Executives
Chairman/Director
Garo Armen
Chief Financial Officer/IR Contact Officer
Alexander Arrow
Director
Jennifer Buell
Director
Robert Stein
Independent Director
Khalil Barrage
Independent Director
Brian Corvese
Independent Director
Joshua Silverman
No Data
About PTIX
Protagenic Therapeutics, Inc., formerly Atrinsic, Inc., is a development-stage company. The Company is a biotechnology company that specializes in the discovery and development of therapeutics to treat central nervous system (CNS) disorders. The Company provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-base, brain active therapeutics. The Company has developed a portfolio of neuropeptides that are in various stages of development and preclinical evaluation for the treatment of various mood disorders. These neuropeptides are called PT00114, PT00121, PT00211, PT00311 and PT00411. As of September 30, 2016, the Company has not generated any revenue.

Webull offers kinds of Protagenic Therapeutics Inc stock information, including NASDAQ:PTIX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PTIX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PTIX stock methods without spending real money on the virtual paper trading platform.